| Literature DB >> 33782137 |
Kakishi Uno1, Ayse Aktalay2, Mariano L Bossi2, Masahiro Irie3, Vladimir N Belov1, Stefan W Hell4,2.
Abstract
The use of photoswitchable fluorescent diarylethenes (fDAEs) as protein labels in fluorescence microscopy and nanoscopy has been limited by labeling inhomogeneity and the need for ultraviolet light for fluorescence activation (on-switching). To overcome these drawbacks, we prepared "turn-on mode" fDAEs featuring thienyl substituents, multiple polar residues, and a reactive maleimide group in the core structure. Conjugates with antibodies and nanobodies displayed complete on-switching and excitation with violet (405 nm) and yellow-green (<565 nm) light, respectively. Besides, they afforded high signal-to-noise ratios and low unspecific labeling in fluorescence imaging. Irradiation with visible light at 532 nm or 561 nm led to transient on-off switching ("blinking") of the fDAEs of double-labeled nanobodies so that nanoscale superresolution images were readily attained through switching and localization of individual fluorophores.Entities:
Keywords: Urbachtail; bioconjugation; chromophores; diarylethenes; fluorescence
Year: 2021 PMID: 33782137 PMCID: PMC8040663 DOI: 10.1073/pnas.2100165118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205
Scheme 1.Synthesis of symmetric (fDAE1-4) and asymmetric hexa-carboxylic acids (fDAE5-6) with a maleimide group. Reagents and conditions: (i) Pd(dba)2, Sphos, K2CO3, aqueous (aq.) THF, reflux, 30 min; (ii) CF3CO2H/CH2Cl2 (1/1, vol/vol), room temperature (r.t.), 1 h; (iii) nBuLi, −90 °C to r.t., 12 h; (iv) 30% aq. H2O2, CH3COOH, reflux, 1 h; (v) I2/H5IO6, concentrated H2SO4, 0 °C, 30 min; (vi) BBr3, DCM, −10 °C to r.t. 24 h; (vii) TEMPO/BAIB, ACN/H2O (1/1, vol/vol), r.t., 30 min; and (viii) TSTU/DIPEA, r.t., 10 min, then E/DIPEA, r.t., 30 min.
Photophysical properties of thienyl-substituted fDAEs in acetonitrile and aqueous (Aq.) buffered solutions (pH = 7, phosphate buffer 100 mM)
| λmaxabs [nm]/ε × 10−3 [M-1cm−1] | λmaxem λfl,max[nm] | Φfl | Φisom/MeCN | Φisom/Aq. buffer | Φfl/ΦCF→OF | |||||
| OF | CF | CFΦOF→CFc | MeCN | Aq. buffer | OF→CFΦOF→CF | CF→OFΦCF→OF | OF→CFΦOF→CF | CF→OFΦCF→OF | Aq. buffer | |
| 360/27.9 | 487/50.0 | 578 | 0.63 | 0.36 | 1.0 × 10−2 | 1.0 × 10−5 | 2.7 × 10−3 | 1.0 × 10−5 | 34,500 | |
| 360/30.6 | 491/54.3 | 575 | 0.61 | 0.37 | 5.3 × 10−3 | 2.5 × 10−4 | 2.7 × 10−3 | 2.9 × 10−4 | 1,270 | |
| 369/19.3 | 504/43.7 | 608 | 0.65 | 0.34 | 9.2 × 10−4 | 3.3 × 10−6 | 2.9 × 10−4 | 3.8 × 10−6 | 88,400 | |
| 368/23.6 | 506/52.8 | 605 | 0.59 | 0.33 | 1.1 × 10−3 | 5.2 × 10−5 | 3.0 × 10−4 | 5.3 × 10−5 | 6,180 | |
| 370/19.1 | 503/41.9 | 606 | 0.48 | 0.29 | 4.6 × 10−4 | 1.1 × 10−5 | 4.0 × 10−4 | 4.3 × 10−6 | 67,700 | |
| 372/25.1 | 505/49.6 | 606 | 0.51 | 0.27 | 1.2 × 10−3 | 1.9 × 10−5 | 3.2 × 10−4 | 1.6 × 10−5 | 17,400 | |
Lowest energy absorption peak.
Fluorescence quantum yield.
Measured at 405 nm or 365 nm.
Measured at 505 nm or 530 nm (see for details).
Fig. 1.(A) Absorption spectra of fDAE1 (black) and fDAE4 (red) in OF (dashed lines) and CF (solid lines), as well as substitution pattern of compounds and emission of the CF in acetonitrile. (B) Conversion (α/1-α) through Urbach tail excitation of the OFs with the corresponding fit according to Eq. . (Inset) Calculated steepness parameters (σ); the substituents at the central positions (as in Scheme 1 and Fig. 1) are indicated.
Fig. 2.Mass analysis and imaging applications of antibodies and nanobodies labeled with fDAEs. (A) Matrix-assisted laser desorption ionization mass spectrometry analysis of a polyclonal secondary antibody labeled with fDAE3. (Lower) The spectra of the unlabeled antibody (black) and the labeled one (red) are shown along with a fit (blue) to a distribution of the shifted curves (representing the addition of dye molecules) with various amplitudes (gray). (Upper) The residuals of the fit. (B) Electrospray ionization mass spectrometry of an anti-GFP nanobody (NBg2a) containing two cysteine residues. The spectra of the unlabeled nanobody (black) and the labeled one (red) are presented, and the molecular mass of the dye (fDAE5) is indicated. (C–E) Superresolution images of U2OS cells expressing rsEGFP2 in vimentin and labeled with a primary and a secondary antibody (C), a primary antibody and a secondary (NBr) nanobody (D), and two anti-GFP nanobodies (NBg2a and NBg2b, 1:1 mixture, in E). The primary antibody used in C and D is the same. (F) (Upper) Average widths of single filaments; each boxplot was calculated from 20 independent measurements. Boxes show the first and third quartiles of data values; the line and the square show the median and the mean values, respectively. Error bars cover the mean value plus and minus 2 times the SD. (Scale bars, 4 μm.) In panels A, B, and F, the schematic representations of the antibodies, nanobodies, GFP, and the fluorescent labels are shown.